Why were Strata Critical Medical (SRTA) restricted stock units linked to share withholdings for Amir Cohen?

The share withholdings occurred because Cohen’s restricted stock units vested, creating taxable income. Instead of paying cash, a portion of the vested shares—9,190 in total—was withheld by the issuer to satisfy tax obligations, which is a common administrative mechanism.

Strata Critical Medical (SRTA) CAO updates tax-withheld share count

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

4/A

Rhea-AI Filing Summary

Strata Critical Medical, Inc. Chief Accounting Officer Amir Cohen reported routine share dispositions related to tax withholding on vested restricted stock units. On September 4, 2025 and September 10, 2025, the issuer withheld a total of 9,190 shares of Class A common stock to satisfy tax obligations. After these withholdings, Cohen directly owns 94,570 shares. This amended filing corrects an earlier Form 4 that had overstated his direct beneficial ownership by 5,483 shares due to an omitted tax-withholding entry.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Cohen Amir

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Tax Withholding	Class A common stock, $0.0001 par value per share	3,707	$4.00	$15K
Tax Withholding	Class A common stock, $0.0001 par value per share	5,483	$4.37	$24K

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 94,570 shares (Direct)

Footnotes (1)

Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. On September 12, 2025, the reporting person filed a Form 4 which reported in column 5 of Table I that, following the withholding of 3,707 shares by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units, the reporting person directly beneficially owned 100,053 shares. In fact, as reflected in this amendment, the reporting person inadvertently failed to disclose the withholding of 5,483 shares by the Issuer on September 4, 2025 to satisfy tax withholding obligations in connection with the vesting of restricted stock units. As such, the reporting person actually directly beneficially owned 94,570 shares following the withholding of 3,707 shares on September 10, 2025. As a result, the original Form 4 mistakenly overstated the reporting person's direct beneficial ownership by 5,483 shares.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

03/23/2026 - 04:02 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cohen Amir

(Last)

(First)

(Middle)

C/O STRATA CRITICAL MEDICAL, INC.

31 HUDSON YARDS, 14TH FLOOR

(Street)

NEW YORK

10001

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
09/12/2025

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A common stock, $0.0001 par value per share	09/04/2025		F⁽¹⁾		5,483	D	$4.37	98,277	D
Class A common stock, $0.0001 par value per share	09/10/2025		F⁽¹⁾		3,707	D	$4	94,570⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

2. On September 12, 2025, the reporting person filed a Form 4 which reported in column 5 of Table I that, following the withholding of 3,707 shares by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units, the reporting person directly beneficially owned 100,053 shares. In fact, as reflected in this amendment, the reporting person inadvertently failed to disclose the withholding of 5,483 shares by the Issuer on September 4, 2025 to satisfy tax withholding obligations in connection with the vesting of restricted stock units. As such, the reporting person actually directly beneficially owned 94,570 shares following the withholding of 3,707 shares on September 10, 2025. As a result, the original Form 4 mistakenly overstated the reporting person's direct beneficial ownership by 5,483 shares.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Amir Cohen	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does Amir Cohen’s amended Form 4/A for Strata Critical Medical (SRTA) report?

The amended Form 4/A reports routine share withholdings used to pay taxes on vested restricted stock units. It clarifies that 9,190 shares of Class A common stock were withheld by the issuer and corrects an earlier overstatement of Cohen’s reported direct holdings.

How many Strata Critical Medical (SRTA) shares were withheld for Amir Cohen’s tax obligations?

A total of 9,190 Class A common shares were withheld to cover Amir Cohen’s tax obligations. This includes 5,483 shares withheld on September 4, 2025 and 3,707 shares withheld on September 10, 2025, all in connection with restricted stock unit vesting.

What are Amir Cohen’s direct Strata Critical Medical (SRTA) holdings after the tax withholdings?

After the tax-related withholdings, Amir Cohen directly owns 94,570 shares of Strata Critical Medical Class A common stock. This updated figure reflects both September 2025 withholding events tied to restricted stock unit vesting and corrects the previously overstated ownership number.

Were Amir Cohen’s Strata Critical Medical (SRTA) transactions open-market sales?

No, these transactions were not open-market sales. The issuer withheld shares to satisfy Amir Cohen’s tax liabilities arising from restricted stock unit vesting. Such F-code transactions represent tax-withholding dispositions back to the company rather than discretionary buying or selling in the market.

What error does the amended Form 4/A correct for Strata Critical Medical (SRTA)?

The amendment corrects a prior Form 4 that failed to report the withholding of 5,483 shares on September 4, 2025. Because of that omission, Cohen’s direct beneficial ownership had been overstated; it should have been 94,570 shares after the September 10, 2025 withholding.